Astraveus Strengthens Leadership Team and Board [Yahoo! Finance]
Charles River Laboratories International, Inc. (CRL)
Last charles river laboratories international, inc. earnings: 2/11 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.criver.com
Company Research
Source: Yahoo! Finance
Laurence Riot Lamotte appointed as Chief Financial Officer New hires reflect continuing progress at Astraveus as Company prepares for launch of the Lakhesys Benchtop Cell Factory™ PARIS April 15, 2025 /PRNewswire/ -- Astraveus SAS ("Astraveus" or the "Company"), the Benchtop Cell Factory company, today announces that it has strengthened its leadership team and Board of Directors with three experienced hires. Jean-Paul Mangeolle joins as Chairman of the Board of Directors, David Newble as a new Independent Board Member, and Laurence Riot Lamotte as Chief Financial Officer. Jean-Paul Mangeolle has over 35 years of experience in life sciences, holding numerous board roles at early-stage and established life sciences companies. He has also held several executive positions at Millipore (now MilliporeSigma) and Danaher. David Newble has also held multiple C-Suite roles across various life sciences technology companies, including the founding of protein analytics company Fluidic Sci
Show less
Read more
Impact Snapshot
Event Time:
CRL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRL alerts
High impacting Charles River Laboratories International, Inc. news events
Weekly update
A roundup of the hottest topics
CRL
News
- Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=CRL&utm_campaign=getratings&utm_medium=online&utm_source=MarkeMarketBeat
- Charles River Laboratories International (NYSE:CRL) had its price target raised by analysts at Mizuho from $174.00 to $200.00. They now have a "neutral" rating on the stock.MarketBeat
- Is Charles River Laboratories Stock Underperforming the Dow? [Yahoo! Finance]Yahoo! Finance
- Charles River Laboratories International (NYSE:CRL) had its price target raised by analysts at JPMorgan Chase & Co. from $165.00 to $190.00. They now have a "neutral" rating on the stock.MarketBeat
- Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $225.00 price target on the stock.MarketBeat
CRL
Earnings
- 11/5/25 - Beat
CRL
Sec Filings
- 12/3/25 - Form 8-K
- 11/17/25 - Form 8-K
- 11/14/25 - Form SCHEDULE
- CRL's page on the SEC website